Evidence map›Paper›PMID 21072171›Full record

ArticlePloS one2010

The regulation of miRNA-211 expression and its role in melanoma cell invasiveness.

Joseph Mazar, Katherine DeYoung, Divya Khaitan, Edward Meister, Alvin Almodovar, James Goydos, Animesh Ray, Ranjan J Perera

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 1 synthesis or guideline pooled it, 204 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. TRP Channels in Skin Cancer: Focus on Malignant Melanoma.International journal of molecular sciences · 2025
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. TRPM2 Channels: A Potential Therapeutic Target in Melanoma?International journal of molecular sciences · 2023
    Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Joseph MazarSanford Burnham Medical Research Institute, Orlando, Florida, United States of America.
Katherine DeYoung
Divya Khaitan
Edward Meister
Alvin Almodovar
James Goydos
Animesh Ray
Ranjan J Perera
Sanford Burnham Prebys Medical Discovery Institute · USSkin Cancer Foundation · USKeck Graduate Institute · USRutgers Cancer Institute of New Jersey

Funding

BiologicalNetworks: Integrated Environment for Systems BiologyR01GM084881 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BAITALUK, MICHAEL · 2008 to 2011
$1.7M
NIGMS NIH HHS 1R01GM084881-01NIGMS NIH HHS R01 GM084881
6 · The paper itself

Abstract

The immediate molecular mechanisms behind invasive melanoma are poorly understood. Recent studies implicate microRNAs (miRNAs) as important agents in melanoma and other cancers. To investigate the role of miRNAs in melanoma, we subjected human melanoma cell lines to miRNA expression profiling, and report a range of variations in several miRNAs. Specifically, compared with expression levels in melanocytes, levels of miR-211 were consistently reduced in all eight non-pigmented melanoma cell lines we examined; they were also reduced in 21 out of 30 distinct melanoma samples from patients, classified as primary in situ, regional metastatic, distant metastatic, and nodal metastatic. The levels of several predicted target mRNAs of miR-211 were reduced in melanoma cell lines that ectopically expressed miR-211. In vivo target cleavage assays confirmed one such target mRNA encoded by KCNMA1. Mutating the miR-211 binding site seed sequences at the KCNMA1 3'-UTR abolished target cleavage. KCNMA1 mRNA and protein expression levels varied inversely with miR-211 levels. Two different melanoma cell lines ectopically expressing miR-211 exhibited significant growth inhibition and reduced invasiveness compared with the respective parental melanoma cell lines. An shRNA against KCNMA1 mRNA also demonstrated similar effects on melanoma cells. miR-211 is encoded within the sixth intron of TRPM1, a candidate suppressor of melanoma metastasis. The transcription factor MITF, important for melanocyte development and function, is needed for high TRPM1 expression. MITF is also needed for miR-211 expression, suggesting that the tumor-suppressor activities of MITF and/or TRPM1 may at least partially be due to miR-211's negative post transcriptional effects on the KCNMA1 transcript. Given previous reports of high KCNMA1 levels in metastasizing melanoma, prostate cancer and glioma, our findings that miR-211 is a direct posttranscriptional regulator of KCNMA1 expression as well as the dependence of this miRNA's expression on MITF activity, establishes miR-211 as an important regulatory agent in human melanoma.

Indexed as

Gene Expression ProfilingGene Expression Regulation, Neoplastic3' Untranslated RegionsBinding SitesBlotting, WesternCell LineCell Line, TumorCell ProliferationCells, CulturedHumansIntronsLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsMelanomaMicroRNAsMutationNeoplasm Invasiveness3' Untranslated RegionsKCNMA1 protein, humanLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsMicroRNAsMIRN211 microRNA, humanTRPM1 protein, humanTRPM Cation Channels

Identifiers

PMID21072171
PMCPMC2967468
OpenAlexW2140937677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.